LifeMap Sciences, a Subsidiary of BioTime, Announces the Release of MalaCards Version 1.02

Published: Jan 09, 2013

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of MalaCards version 1.02 on January 7. The new release is available at MalaCards is a new database of human diseases and their annotations that is modeled on the architecture and richness of the popular GeneCards® database of human genes. LifeMap Sciences holds the exclusive worldwide license to market MalaCards and GeneCards® from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science. MalaCards contains computerized “cards” classifying information relating to a wide array of human diseases. This novel research tool will aid researchers in studying the roles of genes and cells in disease processes. MalaCards and GeneCards® were developed, and are continuously enhanced by ongoing research, by the bioinformatics team at the Department of Molecular Genetics at the Weizmann Institute of Science in Israel, with Professor Doron Lancet, head of the Crown Human Genome Center, and team leader Marilyn Safran.

Back to news